Scottish Prostate Cancer Initiative - Free Testing

FREE PROSTATE CANCER TESTING

Walking Football Scotland is supporting The Scottish Prostate Cancer Initiative, a project offering free PSA tests to 25,000 men in Scotland aged 40–80. Prostate cancer is the most common cancer in men in Scotland, and the Initiative aims to improve the detection and treatment pathway. Since launching in March 2026, more than 10,000 men have already been tested.

We are pleased to offer players access to testing during the Walking Football Scotland Scottish Cup & Festival on Saturday 6 June 2026 at Glasgow Green Football Centre, 28 Kings Drive, Glasgow, G40 1HB.

Testing is by appointment only. A simple blood sample will be taken by the medical team (no physical examination required), and appointments last around 15 minutes. Please drink plenty of water before your appointment (at least 2 litres the day before and on the day) and avoid strenuous exercise for 48 hours beforehand. We are therefore suggesting that, should you wish to book a test, you book a time before playing your first game. The testing event will be opened to the public for appointments later in the day; therefore, please book your appointment by Tuesday 26 May.

Results will be sent directly and confidentially to you by email within a few days. The company will not have access to your results or personal medical information.

To register and book:

· Scan the QR code below, or visit: https://admin.mypsatests.org.uk/Events/?5635d8c4-68d8-4a89-b172-a3166ad48898

· Register with your email address and password

· Select the Walking Football Scotland event on Saturday 6 June 2026

· Enter the event password: WFS26

If you need help registering, call 0800 6523 233.

Some participants may be invited to provide additional samples for research to support the development of more accurate and efficient early diagnosis methods for prostate cancer.

QR Code for Walking Football Scotland testing – 6 June 2026

The Initiative is being supported by Scottish businesses in conjunction with the prostate cancer charity, the Graham Fulford Charitable Trust, and leading UK digital diagnostic company, EDX Medical.